Skip to main content
UniHealth

Doctor search

Yasodha Natkunam, MD

Pathology · Stanford

NPI 1033261151

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Natkunam’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A62254 · Current

Licensed to practise in California · since 1997 · expires 2028-07-31 · Mount Sinai School of Medicine of New York University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$33,070

Medicare paid this office $33,070 for 187 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Special stained specimen slides to examine tissue, each additional procedure63$10,151$25
Surgical pathology consultation and report on referred slides prepared elsewhere70$5,260$75
Surgical pathology consultation and report on referred material requiring preparation of slides48$3,813$79
Flow cytometry technique for dna or cell analysis, 16 or more markers37$2,771$69
Special stained specimen slides to examine tissue, initial procedure69$2,265$31
See all 11 services
Every Original Medicare service billed
Special stained specimen slides to examine tissue, each additional procedure63$10,151$25
Surgical pathology consultation and report on referred slides prepared elsewhere70$5,260$75
Surgical pathology consultation and report on referred material requiring preparation of slides48$3,813$79
Flow cytometry technique for dna or cell analysis, 16 or more markers37$2,771$69
Special stained specimen slides to examine tissue, initial procedure69$2,265$31
Microscopic genetic analysis of tumor, manual31$2,048$37
Genetic sequencing localization, initial procedure42$1,694$38
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure13$1,423$57
Flow cytometry technique for dna or cell analysis, 9 to 15 markers20$1,176$53
Genetic sequencing localization, each additional procedure20$880$30
Pathology examination of tissue using a microscope, intermediate complexity15$640$34

Who their Medicare patients are

187 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 10% · Women 43% · Also on Medicaid 25% · Health risk score 1.68. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 63% · Chronic kidney disease 31% · Coronary heart disease 30% · Diabetes 25% · Atrial fibrillation 25% · Heart failure 23% · Cancer 22% · Depression 21% · COPD 13% · Dementia 10% · Stroke 9%.

The office billed $355,048, Medicare allowed $41,821 and paid $33,070; for 852 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024187852741.68$355,048$33,070
2023187775742.04$266,813$32,746
2022161744741.69$212,288$29,863
2021115686741.73$176,167$27,283
20202111,205731.98$304,855$49,116
2019181989741.87$232,090$39,845
20182831,650731.88$384,458$64,757
20172361,276721.89$291,679$50,906
20162801,347721.85$305,788$54,030
2015180909721.76$200,179$33,123
20143051,347731.80$316,249$47,449
20132661,186711.88$280,006$53,327

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Special stained specimen slides to examine tissue, each additional procedure59$8,767$26
Surgical pathology consultation and report on referred slides prepared elsewhere90$7,037$76
Surgical pathology consultation and report on referred material requiring preparation of slides48$3,997$82
Flow cytometry technique for dna or cell analysis, 16 or more markers35$2,597$74
Special stained specimen slides to examine tissue, initial procedure67$2,243$33
Microscopic genetic analysis of tumor, manual25$2,101$39
Genetic sequencing localization, initial procedure42$1,688$40
Genetic sequencing localization, each additional procedure22$1,079$32
Flow cytometry technique for dna or cell analysis, 9 to 15 markers12$696$58
Pathology examination of tissue using a microscope, intermediate complexity13$556$35

2022: 9 services

Original Medicare services billed in 2022
Special stained specimen slides to examine tissue, each additional procedure65$7,892$25
Surgical pathology consultation and report on referred slides prepared elsewhere75$5,593$75
Surgical pathology consultation and report on referred material requiring preparation of slides54$4,204$76
Special stained specimen slides to examine tissue, initial procedure71$2,500$32
Microscopic genetic analysis of tumor, manual28$2,026$39
Genetic sequencing localization, initial procedure43$1,833$41
Flow cytometry technique for dna or cell analysis, 16 or more markers18$1,465$77
Pathology examination of tissue using a microscope, intermediate complexity17$841$35
Genetic sequencing localization, each additional procedure19$770$32

2021: 8 services

Original Medicare services billed in 2021
Special stained specimen slides to examine tissue, each additional procedure73$8,931$27
Surgical pathology consultation and report on referred material requiring preparation of slides66$5,430$82
Surgical pathology consultation and report on referred slides prepared elsewhere41$3,324$79
Special stained specimen slides to examine tissue, initial procedure77$2,610$33
Microscopic genetic analysis of tumor, manual28$1,842$40
Genetic sequencing localization, initial procedure42$1,743$42
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure14$1,085$60
Genetic sequencing localization, each additional procedure16$775$32

2020: 14 services

Original Medicare services billed in 2020
Special stained specimen slides to examine tissue, each additional procedure83$14,854$28
Surgical pathology consultation and report on referred slides prepared elsewhere93$7,444$77
Surgical pathology consultation and report on referred material requiring preparation of slides68$5,859$85
Microscopic genetic analysis of tumor, manual50$4,166$41
Special stained specimen slides to examine tissue, initial procedure96$3,494$35
Genetic sequencing localization, initial procedure62$2,820$43
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure32$2,621$62
Flow cytometry technique for dna or cell analysis, 16 or more markers26$2,107$78
Pathology examination of tissue using a microscope, intermediate complexity29$1,291$37
Pathology examination of tissue using a microscope, moderately high complexity13$1,224$82
Bone marrow, smear interpretation20$943$47
Genetic sequencing localization, each additional procedure16$810$34
Preparation of tissue for examination by removing any calcium present24$301$12
Special stained specimen slides to examine tissue including interpretation and report13$232$12

2019: 11 services

Original Medicare services billed in 2019
Special stained specimen slides to examine tissue, each additional procedure80$12,830$28
Surgical pathology consultation and report on referred material requiring preparation of slides71$6,238$83
Surgical pathology consultation and report on referred slides prepared elsewhere64$4,744$74
Special stained specimen slides to examine tissue, initial procedure86$3,230$34
Microscopic genetic analysis of tumor, manual37$2,801$41
Genetic sequencing localization, initial procedure61$2,640$42
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure18$2,006$61
Flow cytometry technique for dna or cell analysis, 16 or more markers18$1,281$71
Pathology examination of tissue using a microscope, moderately high complexity11$1,202$80
Genetic sequencing localization, each additional procedure20$930$33
Pathology examination of tissue using a microscope, intermediate complexity14$545$36

2018: 15 services

Original Medicare services billed in 2018
Special stained specimen slides to examine tissue, each additional procedure133$20,748$27
Surgical pathology consultation and report on referred material requiring preparation of slides113$9,294$82
Surgical pathology consultation and report on referred slides prepared elsewhere84$6,419$76
Special stained specimen slides to examine tissue, initial procedure145$5,179$34
Flow cytometry technique for dna or cell analysis, 16 or more markers46$3,757$78
Microscopic genetic analysis of tumor, manual60$3,538$43
Genetic sequencing localization, initial procedure81$3,488$42
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure22$2,453$60
Pathology examination of tissue using a microscope, intermediate complexity45$2,132$36
Pathology examination of tissue using a microscope, moderately high complexity18$1,680$80
Bone marrow, smear interpretation28$1,358$45
Flow cytometry technique for dna or cell analysis, 9 to 15 markers15$1,138$60
Genetic sequencing localization, each additional procedure24$1,058$33
Special stained specimen slides to examine tissue including interpretation and report20$372$11
Preparation of tissue for examination by removing any calcium present28$361$12

2017: 14 services

Original Medicare services billed in 2017
Special stained specimen slides to examine tissue, each additional procedure101$13,393$26
Surgical pathology consultation and report on referred material requiring preparation of slides83$7,018$82
Surgical pathology consultation and report on referred slides prepared elsewhere80$6,258$78
Special stained specimen slides to examine tissue, initial procedure114$4,155$34
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure25$4,002$60
Microscopic genetic analysis of tumor, manual45$3,177$52
Flow cytometry technique for dna or cell analysis, 16 or more markers28$2,415$83
Genetic sequencing localization, initial procedure53$2,265$42
Pathology examination of tissue using a microscope, intermediate complexity48$2,092$36
Bone marrow, smear interpretation36$1,702$46
Genetic sequencing localization, each additional procedure17$793$33
Cell examination of specimen, concentration technique22$517$22
Preparation of tissue for examination by removing any calcium present37$456$12
Special stained specimen slides to examine tissue including interpretation and report19$439$11

2016: 14 services

Original Medicare services billed in 2016
Special stained specimen slides to examine tissue, each additional procedure103$14,592$25
Surgical pathology consultation and report on referred slides prepared elsewhere91$7,088$77
Surgical pathology consultation and report on referred material requiring preparation of slides87$7,030$81
Flow cytometry technique for dna or cell analysis, 16 or more markers41$4,125$101
Special stained specimen slides to examine tissue, initial procedure113$4,011$34
Microscopic genetic analysis of tumor, manual42$2,766$51
Genetic sequencing localization, initial procedure61$2,572$41
Pathology examination of tissue using a microscope, intermediate complexity51$2,362$35
Flow cytometry technique for dna or cell analysis, 9 to 15 markers19$1,841$84
Bone marrow, smear interpretation29$1,312$44
Genetic sequencing localization, each additional procedure18$791$32
Cell examination of specimen, concentration technique21$473$22
Preparation of tissue for examination by removing any calcium present30$387$12
Special stained specimen slides to examine tissue including interpretation and report19$348$11

2015: 13 services

Original Medicare services billed in 2015
Special stained specimen slides to examine tissue, each additional procedure73$7,174$20
Surgical pathology consultation and report on referred material requiring preparation of slides69$5,654$80
Surgical pathology consultation and report on referred slides prepared elsewhere60$4,645$77
Special stained specimen slides to examine tissue, initial procedure85$2,991$33
Genetic sequencing localization, initial procedure49$2,113$41
Microscopic genetic analysis of tumor, manual29$2,064$50
Flow cytometry technique for dna or cell analysis, 16 or more markers19$1,919$101
Pathology examination of tissue using a microscope, intermediate complexity31$1,313$35
Bone marrow, smear interpretation24$1,116$45
Microscopic genetic analysis of tissue, manual, initial procedure17$672$40
Microscopic genetic analysis of tissue, manual, each additional procedure14$603$22
Genetic sequencing localization, each additional procedure18$567$25
Preparation of tissue for examination by removing any calcium present23$290$12

2014: 15 services

Original Medicare services billed in 2014
Surgical pathology consultation and report on referred material requiring preparation of slides86$6,901$78
Surgical pathology consultation and report on referred slides prepared elsewhere79$6,570$74
Flow cytometry technique for dna or cell analysis, 16 or more markers55$5,490$96
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)108$5,434$11
Genetic sequencing localization, initial procedure57$4,254$54
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain117$3,398$27
Microscopic genetic analysis of tumor, manual47$2,838$49
Bone marrow, smear interpretation57$2,685$43
Pathology examination of tissue using a microscope, intermediate complexity63$2,555$35
Flow cytometry technique for dna or cell analysis, 9 to 15 markers24$2,006$77
Flow cytometry technique for dna or cell analysis, 2 to 8 markers14$826$59
Cell examination of specimen, concentration technique25$600$21
Preparation of tissue for examination by removing any calcium present49$589$11
Special stained specimen slides to examine tissue including interpretation and report27$454$11
Blood smear interpretation by physician with written report14$299$21

2013: 11 services

Original Medicare services billed in 2013
Special stained specimen slides to examine tissue, initial procedure108$17,638$38
Surgical pathology consultation and report on referred slides prepared elsewhere75$6,639$71
Flow cytometry technique for dna or cell analysis, 16 or more markers64$5,998$91
Surgical pathology consultation and report on referred material requiring preparation of slides80$5,976$73
Genetic sequencing localization, initial procedure49$3,404$52
Pathology examination of tissue using a microscope, intermediate complexity73$2,849$33
Bone marrow, smear interpretation62$2,751$42
Microscopic genetic analysis of tumor, manual44$2,525$47
Preparation of tissue for examination by removing any calcium present59$680$11
Special stained specimen slides to examine tissue including interpretation and report27$414$11
Cell examination of specimen, concentration technique17$358$20

Medicaid work

$635 in 2020

Medicaid paid $635 for 30 billed services this clinician did in 2020, up to 15 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)30$635
Medicaid work by year
202030115$635
201838123$989
See the largest Medicaid services in earlier years

2018

Largest Medicaid services in 2018
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)38$989

Money from drug and device companies

$17,418 in 2025

Industry payments by year
2025313$14,800$17,418
202434$6,612$6,713
202334$1,820$1,844
202222$5,000$5,000
202122$2,978$2,978
202022$3,013$3,013
201922$1,050$1,083

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Beckman CoulterNone$10,000
1 payment
  • Consulting · 2025-01-07 · $10,000
Roche Molecular SystemsNone$3,834
8 payments
  • Paid to speak or teach · 2025-06-10 · $1,500
  • Travel · 2025-04-03 · $34
  • Travel · 2025-04-01 · $279
  • Travel · 2025-04-01 · $568
  • Education · 2025-04-01 · $850
  • Travel · 2025-03-31 · $279
  • Travel · 2025-03-31 · $45
  • Travel · 2025-03-30 · $279
Ventana Medical SystemsCintec Plus Cytology$3,584
4 payments
  • Paid to speak or teach · 2025-06-18 · $900
  • Meals for Cintec Plus Cytology · 2025-03-30 · $72
  • Travel · 2025-02-06 · $212
  • Paid to speak or teach · 2025-02-06 · $2,400
See all 13 published payments
Every published payment
Ventana Medical SystemsPaid to speak or teach · 2025-06-18None$900
Roche Molecular SystemsPaid to speak or teach · 2025-06-10None$1,500
Roche Molecular SystemsTravel · 2025-04-03None$34
Roche Molecular SystemsTravel · 2025-04-01None$279
Roche Molecular SystemsTravel · 2025-04-01None$568
Roche Molecular SystemsEducation · 2025-04-01None$850
Roche Molecular SystemsTravel · 2025-03-31None$279
Roche Molecular SystemsTravel · 2025-03-31None$45
Ventana Medical SystemsMeals · 2025-03-30Cintec Plus Cytology$72
Roche Molecular SystemsTravel · 2025-03-30None$279
Ventana Medical SystemsTravel · 2025-02-06None$212
Ventana Medical SystemsPaid to speak or teach · 2025-02-06None$2,400
Beckman CoulterConsulting · 2025-01-07None$10,000
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $6,713

Payments by company in 2024
Leica MicrosystemsBond-Prime Automated Stainer$4,000
1 payment
  • Consulting for Bond-Prime Automated Stainer · 2024-04-10 · $4,000
Ventana Medical SystemsNone$2,612
1 payment
  • Paid to speak or teach · 2024-12-10 · $2,612
Roche Molecular SystemsNone$101
2 payments
  • Meals · 2024-09-20 · $87
  • Travel · 2024-09-17 · $14

2023: $1,844

Payments by company in 2023
Leica MicrosystemsBond-III Processing Module$1,500
1 payment
  • Consulting for Bond-III Processing Module · 2023-04-23 · $1,500
AstraZeneca Pharmaceuticals LPNone$252
2 payments
  • Travel · 2023-10-27 · $23
  • Paid to speak or teach · 2023-10-02 · $229
Taiho OncologyNone$91
1 payment
  • Paid to speak or teach · 2023-10-02 · $91

2022: $5,000

Payments by company in 2022
Leica MicrosystemsBond-Prime Automated Stainer$4,500
1 payment
  • Consulting for Bond-Prime Automated Stainer · 2022-09-22 · $4,500
Ventana Medical SystemsNone$500
1 payment
  • Paid to speak or teach · 2022-12-13 · $500

2021: $2,978

Payments by company in 2021
GenentechNone$1,978
1 payment
  • Consulting · 2021-02-18 · $1,978
Ventana Medical SystemsNone$1,000
1 payment
  • Consulting · 2021-06-10 · $1,000

2020: $3,013

Payments by company in 2020
F. Hoffmann-La Roche AGVenclexta$1,978
1 payment
  • Consulting for Venclexta · 2020-12-10 · $1,978
Chugai Pharmaceutical Co.Rituxan$1,036
1 payment
  • Consulting for Rituxan · 2020-05-28 · $1,036

2019: $1,083

Payments by company in 2019
Stemline TherapeuticsNone$1,050
1 payment
  • Consulting · 2019-08-15 · $1,050
Seattle GeneticsNone$33
1 payment
  • Meals · 2019-09-13 · $33

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
VENTANA MEDICAL SYSTEMS, INC. · Ventana Kappa and Lambda Dual Ish Mrna Probe Cocktail · 2025Their institution$255,992

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1033261151
Licence
CA A62254California A62254: Current · expires 2028-07-31
Trained
Icahn School of Medicine at Mount Sinai, 1995
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
CA 00A622540
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0101X (207ZP0101X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-01-17
NPI last updated
2024-03-14
NPI record certified
2024-03-14

This is when the NPI record was last certified, not a medical board exam.